Daniel Lochner

Insider Reports History

Location
Watertown, MA
Signature
/s/ Daniel Lochner
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel Lochner:

Company Role Class Num Shares Value Price $ Report Date Ownership
Tectonic Therapeutic, Inc. Chief Financial Officer Common Stock 32,044 $692,470 $21.61 10 Feb 2026 Direct
Tectonic Therapeutic, Inc. Chief Financial Officer Employee Stock Option (Right to Buy) 9,860 25 Sep 2025 Direct
Oyster Point Pharma, Inc. Chief Financial Officer Common Stock 0 $11.20 03 Jan 2023 Direct
Oyster Point Pharma, Inc. Chief Financial Officer Performance Stock Units 0 03 Jan 2023 Direct
Oyster Point Pharma, Inc. Chief Financial Officer Stock Option (Right to Buy) 0 03 Jan 2023 Direct

Insider Reports Filed by Daniel Lochner

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TECX Tectonic Therapeutic, Inc. 10 Feb 2026 1 +$129,660 4 Chief Financial Officer 11 Feb 2026, 17:32
TECX Tectonic Therapeutic, Inc. 04 Feb 2026 1 -$48,228 4 Chief Financial Officer 10 Feb 2026, 16:04
TECX Tectonic Therapeutic, Inc. 25 Sep 2025 2 $0 4 Chief Financial Officer 29 Sep 2025, 17:00
TECX Tectonic Therapeutic, Inc. 05 Feb 2025 1 +$249,964 4 Chief Financial Officer 07 Feb 2025, 16:19
TECX Tectonic Therapeutic, Inc. 04 Feb 2025 2 $0 4 Chief Financial Officer 06 Feb 2025, 16:05
TECX Tectonic Therapeutic, Inc. 20 Jun 2024 1 $0 4 Chief Financial Officer 24 Jun 2024, 16:18
TECX Tectonic Therapeutic, Inc. 20 Jun 2024 0 $0 3 Chief Financial Officer 24 Jun 2024, 16:17
/report/000120919122059938-lochner-daniel-2022-12-01 Oyster Point Pharma, Inc. 01 Dec 2022 1 -$36,490 4 Chief Financial Officer 06 Dec 2022, 07:50
/report/000120919122041676-lochner-daniel-2022-07-06 Oyster Point Pharma, Inc. 06 Jul 2022 1 $0 4 Chief Financial Officer 08 Jul 2022, 16:55
/report/000120919123001073-lochner-daniel-2022-01-29 Oyster Point Pharma, Inc. 29 Jan 2022 9 -$10,975 4 Chief Financial Officer 04 Jan 2023, 16:04
/report/000120919122002978-lochner-daniel-2022-01-09 Oyster Point Pharma, Inc. 09 Jan 2022 2 $0 4 Chief Financial Officer 11 Jan 2022, 18:45
/report/000120919121062476-lochner-daniel-2021-11-01 Oyster Point Pharma, Inc. 01 Nov 2021 2 +$98,871 4 Chief Financial Officer 02 Nov 2021, 17:49
/report/000120919121054919-lochner-daniel-2021-09-02 Oyster Point Pharma, Inc. 02 Sep 2021 2 +$86,325 4 Chief Financial Officer 07 Sep 2021, 08:03
/report/000120919121053844-lochner-daniel-2021-08-26 Oyster Point Pharma, Inc. 26 Aug 2021 1 $0 4 Chief Financial Officer 30 Aug 2021, 16:52
/report/000120919121048517-lochner-daniel-2021-07-28 Oyster Point Pharma, Inc. 28 Jul 2021 2 +$86,325 4 Chief Financial Officer 29 Jul 2021, 17:05